Mr. Edward J. Borkowski has over 31 years of public company audit and accounting experience including 21 years at major pharmaceutical companies and more than 10 years experience as a Chief Financial Officer serving multi-billion dollar pharmaceutical companies and healthcare related companies. In June 2015 he was elected to Concordia healthcare’s Board of Directors and in February 2016 became its Executive Vice President responsible for corporate administration, investor relations, public relations and strategy. Previously he was the Chief Financial Officer of Amerigen Pharmaceuticals, Convatex, CareFusion and Mylan N.V. Mr. Borkowski is currently the Chairman of AzurRx. AzurRx, a biopharmaceutical company and is also on the Boards of Transdermal Delivery Systems and Wherever TV Broadcasting Group. During his executive career, Mr. Borkowski has led and managed billions of dollars in acquisitions, financings, and equity offerings.
He is a Member of the American Institute of Certified Public Accountants and the New York State Society of CPAs, and started his career with Arthur Anderson, LLP. Mr. Borkowski holds a Bachelor of Science in Economics and Political Science from Allegheny College and a Master in Business Administration in Finance and Accounting from Rutgers University. He also serves as a trustee and on the Executive committee of Allegheny College.